What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?
Top Cited Papers
- 1 November 2015
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurosurgery
- Vol. 77 (5), 663-673
- https://doi.org/10.1227/neu.0000000000000929
Abstract
The current neurosurgical goal for patients with malignant gliomas is maximal safe resection of the contrast-enhancing tumor. However, a complete reseKeywords
This publication has 56 references indexed in Scilit:
- Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarkerJournal of Neurosurgery, 2011
- Finding the anaplastic focus in diffuse gliomas: The value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescenceClinical Neurology and Neurosurgery, 2011
- Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid–induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parametersJournal of Neurosurgery, 2011
- Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection studyJournal of Neurosurgery, 2011
- Hot spots in dynamic18FET-PET delineate malignant tumor parts within suspected WHO grade II gliomasNeuro-Oncology, 2011
- Precise comparison of protoporphyrin IX fluorescence spectra with pathological results for brain tumor tissue identificationBrain Tumor Pathology, 2010
- Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experienceJournal of Neuro-Oncology, 2010
- 5‐Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancementCancer, 2010
- FIVE-AMINOLEVULINIC ACID FOR FLUORESCENCE-GUIDED RESECTION OF RECURRENT MALIGNANT GLIOMASNeurosurgery, 2009
- EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORMENeurosurgery, 2008